Amesite Inc. (NASDAQ: AMST) Announces That it Has Regained Compliance with Nasdaq Listing Requirements

DETROIT, March 09, 2023 (GLOBE NEWSWIRE) — Amesite Inc. (NASDAQ: AMST), a leading artificial intelligence software company offering a cloud-based learning platform that delivers 99% learner retention for business and education markets, announced today that it has received confirmation from The Nasdaq Stock Market LLC (“Nasdaq”) that it has regained compliance with the minimum bid […]

Expion360 (NASDAQ:XPON) Chosen as Exclusive Lithium-Ion Battery Supplier for Xtreme Outdoors Teardrop Campers

REDMOND, OR / ACCESSWIRE / March 9, 2023 / Expion360, Inc. (NASDAQ:XPON), an industry leader in lithium-ion battery power storage solutions, has been chosen as the exclusive supplier of high-energy lithium-ion batteries and power system components for all Little Guy lightweight camper trailers manufactured by Xtreme Outdoors. Expion360 Inc., Thursday, March 9, 2023, Press release picture Expion360 state-of-the-art […]

Laser Photonics (NASDAQ:LASE) Announces Initiative to Drive Expansion of Service Partner Network

ORLANDO, FL / ACCESSWIRE / March 9, 2023 / Laser Photonics Corporation (NASDAQ:LASE) (“LPC”), a leading global developer of industrial CleanTech laser systems for laser cleaning and other materials applications, today announced the expansion of its Service Partner Network (SPN) program. Wayne Tupuola, chief executive officer of Laser Photonics, commented, “The SPN is an integral part of our […]

SciSparc (Nasdaq: SPRC) Receives Approval to conduct its Phase IIb Clinical Trial for SCI-110 to treat Tourette Syndrome

TEL AVIV, Israel, March 09, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced the approval of the Israeli Ministry of Health to conduct its clinical trial titled “A randomized, double-blind, […]

Mawson Infrastructure Group Inc. (NASDAQ:MIGI) Announces February 2023 Operational Update

SHARON, Pa., March 09, 2023–(BUSINESS WIRE)–Mawson Infrastructure Group Inc. (NASDAQ:MIGI) (“Mawson” or the “Company”), a digital infrastructure provider, announced today its unaudited Bitcoin production and operational update for February 2023. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230309005253/en/ James Manning, CEO, commented, “February was an exciting month for operational development, with the commencement of […]

Grom’s (NASDAQ: GROM) Top Draw Animation Secures Assignment to Animate Bidaya Media’s Hit Series, Mansour

BOCA RATON, Fla., March 08, 2023 (GLOBE NEWSWIRE) — Grom Social Enterprises Inc. (NASDAQ: GROM) (“Grom” or the “Company”), a media, technology and entertainment company dedicated to family-friendly programming, web filtering technology, and safe social media for kids, today announced that its subsidiary Top Draw Animation (“TDA”), a leading source of premium animation production services […]

Jupiter Wellness (NASDAQ:JUPW) Launches Clinical Trial of Jellyfish Sting Prevention Sunscreen on Man-O-War

JUPITER, FL / ACCESSWIRE / March 7, 2023 / Jupiter Wellness, Inc. (NASDAQ:JUPW), a wellness company focused on hair, skin, and sexual wellness announced today the launch of a clinical trial to evaluate the efficacy of an improved formulation of NoStingz jellyfish sting prevention sunscreen against man-o-war jellyfish. The trial, conducted by Angelshark Consulting and led by […]

SciSparc (Nasdaq: SPRC) Successfully Completed Production of its Proprietary Drug Candidate SCI-110 for its Upcoming Clinical Trial On Tourette Syndrome

TEL AVIV, Israel, March 06, 2023 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC) (the “Company” or “SciSparc”), a specialty, clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that it has successfully manufactured clinical batches of its top-tier drug candidate SCI-110 to be used in […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.